0001555280-21-000100.txt : 20210216 0001555280-21-000100.hdr.sgml : 20210216 20210216171616 ACCESSION NUMBER: 0001555280-21-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Robert Edward CENTRAL INDEX KEY: 0001798683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 21640844 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_161351374187911.xml FORM 4 X0306 4 2021-02-11 0 0001555280 Zoetis Inc. ZTS 0001798683 Kelly Robert Edward C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Executive Vice President Common Stock 2021-02-11 4 M 0 821 26 A 10029 D Common Stock 2021-02-11 4 M 0 729 30.89 A 10758 D Common Stock 2021-02-11 4 S 0 2054 161.15 D 8704 D Stock Option 2021-02-11 4 M 0 821 0 D Common Stock 821.0 51513 D Stock Option 2021-02-11 4 M 0 729 0 D Common Stock 729.0 50784 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. 821 options granted January 31, 2013 at an exercise price of $26.00 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. 729 options granted March 4, 2014 at an exercise price of $30.89 per option. 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,010 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. /s/ Katherine H. Walden, as Attorney-in-Fact 2021-02-16